Scholarlink

<p>Circular mRNA faces challenges in enhancing its translation potential as an RNA therapeutic. Here we introduce two molecular designs that bolster circular mRNA translation through an internal cap-initiated mechanism. The first consists of a circular mRNA with a covalently attached <i>N</i><sup>7</sup>-methylguanosine (m<sup>7</sup>G) cap through a branching structure (cap-circ mRNA). This modification allows circular mRNA to recruit translation machinery and produce proteins more efficiently than internal ribosome entry site (IRES)-containing circular mRNAs. Combining with an <i>N</i><sup>1</sup>-methylpseudouridine (m<sup>1</sup>Ψ) modification, cap-circ mRNA exhibits a lower acute immunostimulatory effect, maintaining high translation in mice. The second design features the non-covalent attachment of an m<sup>7</sup>G cap to a circular mRNA through hybridization with an m<sup>7</sup>G cap-containing oligonucleotide, enhancing translation by more than 50-fold. This setup allows circular mRNAs to synthesize reporter proteins upon hybridizing with capped mRNAs or long non-coding RNAs and to undergo rolling circle-type translation. These advancements broaden the therapeutic applications of circular mRNAs by minimizing their molecular size, elevating translation efficiency and facilitating cell-type-selective translation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Internal cap-initiated translation for efficient protein production from circular mRNA

  • 期刊论文

  • 发表日期：

    2025年2月19日

查看全文
  • Kosuke Fukuchi,
  • Yuko Nakashima,
  • Naoko Abe,
  • Seigo Kimura,
  • Fumitaka Hashiya,
  • Yuichi Shichino,
  • Yiwei Liu,
  • Ryoko Ogisu,
  • Satomi Sugiyama,
  • Daisuke Kawaguchi,
  • Masahito Inagaki,
  • Zheyu Meng,
  • Shiryu Kajihara,
  • Mizuki Tada,
  • Satoshi Uchida,
  • Ting-Ting Li,
  • Ramkrishna Maity,
  • Tairin Kawasaki,
  • Yasuaki Kimura,
  • Shintaro Iwasaki,
  • Hiroshi Abe

摘要

Circular mRNA faces challenges in enhancing its translation potential as an RNA therapeutic. Here we introduce two molecular designs that bolster circular mRNA translation through an internal cap-initiated mechanism. The first consists of a circular mRNA with a covalently attached N7-methylguanosine (m7G) cap through a branching structure (cap-circ mRNA). This modification allows circular mRNA to recruit translation machinery and produce proteins more efficiently than internal ribosome entry site (IRES)-containing circular mRNAs. Combining with an N1-methylpseudouridine (m1Ψ) modification, cap-circ mRNA exhibits a lower acute immunostimulatory effect, maintaining high translation in mice. The second design features the non-covalent attachment of an m7G cap to a circular mRNA through hybridization with an m7G cap-containing oligonucleotide, enhancing translation by more than 50-fold. This setup allows circular mRNAs to synthesize reporter proteins upon hybridizing with capped mRNAs or long non-coding RNAs and to undergo rolling circle-type translation. These advancements broaden the therapeutic applications of circular mRNAs by minimizing their molecular size, elevating translation efficiency and facilitating cell-type-selective translation.